Skip to main content
All lobbying filings

KING & SPALDING LLP

Lobbying for KANEKA PHARMA AMERICA, LLC · Distributor of life science systems

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 17, 2025
Income
$40,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Lobbyists on this filing 2
  • PREEYA NORONHA PINTO
    Previously held: Deputy GC, Principal Deputy GC, Acting GC, HHS
  • SCOTT DZIENGELSKI
    Previously held: Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst.(2013-2015), Leg. Asst. (2012-2013), Leg. Corr. (2011-2012),Staff Asst. (2010-2011); Energy and Commerce Committee:Staff (2015-2017)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 8999 (118th Cong.).

 Bills named in this filing 1
  • H.R. 8999
    Dialysis-Related Amyloidosis Treatment Act of 2024

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem